Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy

Thomas R. OʼBrien; David H. McDermott; John P A Ioannidis; Mary Carrington; Philip M. Murphy; Diane V. Havlir; Douglas D. Richman

doi:10.1097/00002030-200005050-00008

Related publications

Article1998

A novel lipopolysaccharide inducible C‐C chemokine receptor related gene in murine macrophages

Takahiro Shimada, Makoto Matsumoto, Yoichi Tatsumi, Akihisa Kanamaru, Akira Shizuo

FEBS Letters

Article1999

Up-Regulation of CCR2 Chemokine Receptor Expression and Increased Susceptibility to the Multitropic HIV Strain 89.6 in Monocytes Exposed to Glucocorticoid Hormones

Giselle Pentón‐Rol, Manuela Cota, Nadia Polentarutti, Walter Luini, Sergio Bernasconi, Alessandro Borsatti, Antonio Sica, Gregory J. LaRosa, Silvano Sozzani, Guido Poli, Alberto Mantovani

Article1999

The LD78β isoform of MIP-1α is the most potent CCR5 agonist and HIV-1–inhibiting chemokine

Patricia Menten, Sofie Struyf, Evemie Schutyser, Anja Wuyts, De Clercq Erik, Dominique Schols, Paul Proost, Jo Van Damme

Article2012

CXCR4 chemokine receptor antagonists: nickel(ii) complexes of configurationally restricted macrocycles

Rachel Smith, Dana Huskens, Dirk Daelemans, Ryan E. Mewis, Courtney D. Garcia, Amy N. Cain, TaRynn N. Carder Freeman, Christophe Pannecouque, De Clercq Erik, Dominique Schols, Timothy J. Hubin, Stephen J. Archibald

Article2002

Responses of Leukocytes to Chemokines in Whole Blood and Their Antagonism by Novel CC-Chemokine Receptor 3 Antagonists

Shannon A. Bryan, Peter J. Jose, Joanna R. Topping, Robert S. Wilhelm, Carol Soderberg, D Kertesz, Peter J Barnes, Timothy J. Williams, Trevor T. Hansel, Ian Sabroe